Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2017

Open Access 01-12-2017 | Study protocol

The NAPRESSIM trial: the use of low-dose, prophylactic naloxone infusion to prevent respiratory depression with intrathecally administered morphine in elective hepatobiliary surgery: a study protocol and statistical analysis plan for a randomised controlled trial

Authors: David Cosgrave, Marie Galligan, Era Soukhin, Victoria McMullan, Siobhan McGuinness, Anand Puttappa, Niamh Conlon, John Boylan, Rabia Hussain, Peter Doran, Alistair Nichol

Published in: Trials | Issue 1/2017

Login to get access

Abstract

Background

Intrathecally administered morphine is effective as part of a postoperative analgesia regimen following major hepatopancreaticobiliary surgery. However, the potential for postoperative respiratory depression at the doses required for effective analgesia currently limits its clinical use. The use of a low-dose, prophylactic naloxone infusion following intrathecally administered morphine may significantly reduce postoperative respiratory depression. The NAPRESSIM trial aims to answer this question.

Methods/design

‘The use of low-dose, prophylactic naloxone infusion to prevent respiratory depression with intrathecally administered morphine’ trial is an investigator-led, single-centre, randomised, double-blind, placebo-controlled, double-arm comparator study. The trial will recruit 96 patients aged > 18 years, undergoing major open hepatopancreaticobiliary resections, who are receiving intrathecally administered morphine as part of a standard anaesthetic regimen. It aims to investigate whether the prophylactic administration of naloxone via intravenous infusion compared to placebo will reduce the proportion of episodes of respiratory depression in this cohort of patients.
Trial patients will receive an infusion of naloxone or placebo, commenced within 1 h of postoperative extubation continued until the first postoperative morning. The primary outcome is the rate of respiratory depression in the intervention group as compared to the placebo group. Secondary outcomes include pain scores, rates of nausea and vomiting, pruritus, sedation scores and adverse outcomes. We will also employ a novel, non-invasive, respiratory minute volume monitor (ExSpiron 1Xi, Respiratory Motion, Inc., 411 Waverley Oaks Road, Building 1, Suite 150, Waltham, MA, USA) to assess the monitor’s accuracy for detecting respiratory depression.

Discussion

The trial aims to provide a clear management plan to prevent respiratory depression after the intrathecal administration of morphine, and thereby improve patient safety.

Trial registration

ClinicalTrials.gov, ID: NCT02885948. Registered retrospectively on 4 July 2016.
Protocol Version 2.0, 3 April 2017.
Protocol identification (code or reference number): UCDCRC/15/006
EudraCT registration number: 2015-003504-22. Registered on 5 August 2015.
Appendix
Available only for authorised users
Literature
1.
Hughes M, et al. Effect of analgesic modality on outcome following open liver surgery: a systematic review of postoperative analgesia. Minerva Anestesiol. 2015;81(5):541–56.PubMed
2.
Revie EJ, et al. Effectiveness of epidural analgesia following open liver resection. HPB (Oxford). 2011;13(3):206–11.CrossRef
3.
Tzimas P, et al. Epidural anaesthesia and analgesia for liver resection. Anaesthesia. 2013;68(6):628–35.CrossRefPubMed
4.
5.
Amini N, et al. A nationwide analysis of the use and outcomes of perioperative epidural analgesia in patients undergoing hepatic and pancreatic surgery. Am J Surg. 2015;210(3):483–91.CrossRefPubMedPubMedCentral
6.
Rosero EB, et al. Evaluation of epidural analgesia for open major liver resection surgery from a US inpatient sample. Proc (Bayl Univ Med Cent). 2014;27(4):305–12.CrossRef
7.
8.
9.
Sanford DE, Hawkins WG, Fields RC. Improved peri-operative outcomes with epidural analgesia in patients undergoing a pancreatectomy: a nationwide analysis. HPB. 2012;17(6):551–8. doi:10.​1111/​hpb.​12392. Epub 2015 Feb 28.
10.
Zimmitti G, et al. Positive impact of epidural analgesia on oncologic outcomes in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol. 2016;23(3):1003–11.CrossRefPubMed
11.
Feltracco P, et al. Epidural anesthesia and analgesia in liver resection and living donor hepatectomy. Transplant Proc. 2008;40(4):1165–8.CrossRefPubMed
12.
Freise H, Van Aken HK. Risks and benefits of thoracic epidural anaesthesia. Br J Anaesth. 2011;107(6):859–68.CrossRefPubMed
13.
14.
Marandola M, et al. Perioperative management in patients undergoing pancreatic surgery: the anesthesiologist’s point of view. Transplant Proc. 2008;40(4):1195–9.CrossRefPubMed
15.
Rawal N. Epidural technique for postoperative pain: gold standard no more? Reg Anesth Pain Med. 2012;37(3):310–7.CrossRefPubMed
16.
Ready LB. Acute pain: lessons learned from 25,000 patients. Reg Anesth Pain Med. 1999;24(6):499–505.PubMed
17.
Matot I, et al. Epidural anesthesia and analgesia in liver resection. Anesth Analg. 2002;95(5):1179–81. Table of contents.CrossRefPubMed
18.
McLeod G, et al. Postoperative pain relief using thoracic epidural analgesia: outstanding success and disappointing failures. Anaesthesia. 2001;56(1):75–81.CrossRefPubMed
19.
Hughes MJ, et al. Randomized clinical trial of perioperative nerve block and continuous local anaesthetic infiltration via wound catheter versus epidural analgesia in open liver resection (LIVER 2 trial). Br J Surg. 2015;102(13):1619–28.CrossRefPubMed
20.
Cook TM, et al. Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth. 2009;102(2):179–90.CrossRefPubMed
21.
Stamenkovic DM, et al. Epidural analgesia and liver resection: postoperative coagulation disorders and epidural catheter removal. Minerva Anestesiol. 2011;77(7):671–9.PubMed
22.
Karna ST, et al. Postoperative coagulopathy after live related donor hepatectomy: incidence, predictors and implications for safety of thoracic epidural catheter. J Postgrad Med. 2015;61(3):176–80.CrossRefPubMedPubMedCentral
23.
Lim HJ, Koay CK, Lee LS. Postoperative coagulopathy after liver resection—implications for epidural analgesia. Anaesth Intensive Care. 2006;34(1):118–9.PubMed
24.
Jones C, et al. Randomized clinical trial on enhanced recovery versus standard care following open liver resection. Br J Surg. 2013;100(8):1015–24.CrossRefPubMed
25.
Kelliher L, Jones C, Fawcett W. Enhanced recovery for gastrointestinal surgery. BJA Education. 2015;15(6):305–10.CrossRef
26.
Sakowska M, et al. A change in practice from epidural to intrathecal morphine analgesia for hepato-pancreato-biliary surgery. World J Surg. 2009;33(9):1802–8.CrossRefPubMed
27.
Kasivisvanathan R, et al. A prospective cohort study of intrathecal versus epidural analgesia for patients undergoing hepatic resection. HPB (Oxford). 2014;16(8):768–75.CrossRef
28.
Roy JD, et al. A comparison of intrathecal morphine/fentanyl and patient-controlled analgesia with patient-controlled analgesia alone for analgesia after liver resection. Anesth Analg. 2006;103(4):990–4.CrossRefPubMed
29.
Meylan N, et al. Benefit and risk of intrathecal morphine without local anaesthetic in patients undergoing major surgery: meta-analysis of randomized trials. Br J Anaesth. 2009;102(2):156–67.CrossRefPubMed
30.
Koea JB, Young Y, Gunn K. Fast track liver resection: the effect of a comprehensive care package and analgesia with single dose intrathecal morphine with gabapentin or continuous epidural analgesia. HPB Surgery, 2009. 2009.
31.
De Pietri L, et al. The use of intrathecal morphine for postoperative pain relief after liver resection: a comparison with epidural analgesia. Anesth Analg. 2006;102(4):1157–63.CrossRefPubMed
32.
Fares KM, Mohamed SA, Abdel-Ghaffar HS. High dose intrathecal morphine for major abdominal cancer surgery: a prospective double-blind, dose-finding clinical study. Pain Physician. 2014;17(3):255–64.PubMed
33.
Carvalho FA, Tenorio SB. Comparative study between doses of intrathecal morphine for analgesia after caesarean. Braz J Anesthesiol. 2013;63(6):492–9.CrossRefPubMed
34.
Hassett P, et al. Determination of the efficacy and side-effect profile of lower doses of intrathecal morphine in patients undergoing total knee arthroplasty. BMC Anesthesiol. 2008;8:5.CrossRefPubMedPubMedCentral
35.
Gehling M, Tryba M. Risks and side-effects of intrathecal morphine combined with spinal anaesthesia: a meta-analysis. Anaesthesia. 2009;64(6):643–51.CrossRefPubMed
36.
Bailey PL, et al. Dose-response pharmacology of intrathecal morphine in human volunteers. Anesthesiology. 1993;79(1):49–59. discussion 25A.CrossRefPubMed
37.
Jacobson L, Chabal C, Brody MC. A dose-response study of intrathecal morphine: efficacy, duration, optimal dose, and side effects. Anesth Analg. 1988;67(11):1082–8.CrossRefPubMed
38.
Clergue F, et al. Respiratory effects of intrathecal morphine after upper abdominal surgery. Anesthesiology. 1984;61(6):677–85.CrossRefPubMed
39.
Gwirtz KH, et al. The safety and efficacy of intrathecal opioid analgesia for acute postoperative pain: seven years’ experience with 5969 surgical patients at Indiana University Hospital. Anesth Analg. 1999;88(3):599–604.PubMed
40.
American Society of Anesthesiologists Task Force on Neuraxial Opioids and the American Society of Regional Anesthesia and Pain Medicine. Practice Guidelines for the Prevention, Detection, and Management of Respiratory Depression Associated with Neuraxial Opioid Administration: An Updated Report by the American Society of Anesthesiologists Task Force on Neuraxial Opioids and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology, 2016. 124(3): p. 535–52
41.
Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010;112(1):226–38.CrossRefPubMed
42.
Sultan P, Gutierrez MC, Carvalho B. Neuraxial morphine and respiratory depression: finding the right balance. Drugs. 2011;71(14):1807–19.CrossRefPubMed
43.
Shapiro A, et al. The frequency and timing of respiratory depression in 1524 postoperative patients treated with systemic or neuraxial morphine. J Clin Anesth. 2005;17(7):537–42.CrossRefPubMed
44.
Hindle A. Intrathecal opioids in the management of acute postoperative pain. Contin Educ Anaesth Crit Care Pain. 2008;8(3):81–5.CrossRef
45.
Ko S, Goldstein DH, VanDenKerkhof EG. Definitions of ‘respiratory depression’ with intrathecal morphine postoperative analgesia: a review of the literature. Can J Anaesth. 2003;50(7):679–88.CrossRefPubMed
46.
47.
Horlocker TT, et al. Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration. Anesthesiology. 2009;110(2):218–30.PubMed
48.
Mugabure Bujedo B. A clinical approach to neuraxial morphine for the treatment of postoperative pain. Pain Res Treat. 2012;2012:612145.PubMedPubMedCentral
49.
Bujedo BM, Santos SG, Azpiazu AU. A review of epidural and intrathecal opioids used in the management of postoperative pain. J Opioid Manag. 2012;8(3):177–92.CrossRefPubMed
50.
DeSousa KA. Intrathecal morphine for postoperative analgesia: current trends. World J Anesthesiol. 2014;3(3):191.CrossRef
51.
Longnecker DE, Grazis PA, Eggers Jr GW. Naloxone for antagonism of morphine-induced respiratory depression. Anesth Analg. 1973;52(3):447–53.CrossRefPubMed
52.
Dailey PA, et al. The effects of naloxone associated with the intrathecal use of morphine in labor. Anesth Analg. 1985;64(7):658–66.CrossRefPubMed
53.
Luthman JA, Kay NH, White JB. Intrathecal morphine for post caesarean section analgesia: does naloxone reduce the incidence of pruritus? Int J Obstet Anesth. 1992;1(4):191–4.CrossRefPubMed
54.
Rebel A, Sloan P, Andrykowski M. Postoperative analgesia after radical prostatectomy with high-dose intrathecal morphine and intravenous naloxone: a retrospective review. J Opioid Manag. 2009;5(6):331–9.PubMed
55.
Rebel A, Sloan P, Andrykowski M. Retrospective analysis of high-dose intrathecal morphine for analgesia after pelvic surgery. Pain Res Manag. 2011;16(1):19–26.CrossRefPubMedPubMedCentral
Metadata
Title
The NAPRESSIM trial: the use of low-dose, prophylactic naloxone infusion to prevent respiratory depression with intrathecally administered morphine in elective hepatobiliary surgery: a study protocol and statistical analysis plan for a randomised controlled trial
Authors
David Cosgrave
Marie Galligan
Era Soukhin
Victoria McMullan
Siobhan McGuinness
Anand Puttappa
Niamh Conlon
John Boylan
Rabia Hussain
Peter Doran
Alistair Nichol
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-017-2370-0

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue

Study protocol

Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial

Study protocol

Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial

Study protocol

A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma – the STRONG study: study protocol for a randomised controlled trial

Research

Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial

Study protocol

The effects of using the PReDicT Test to guide the antidepressant treatment of depressed patients: study protocol for a randomised controlled trial

Research

Exploring patients’ treatment journeys following randomisation in mental health trials to improve future trial conduct: a synthesis of multiple qualitative data sets